REGISTERED NUMBER: 10521383 (England and Wales)

Financial Statements

for the Year Ended 31 December 2024

for

RNA ANALYTICS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

H K Kim

REGISTERED OFFICE:

First Floor, Bancroft Place

10 Bancroft Road

Reigate

Surrey

RH2 7RP

REGISTERED NUMBER:

10521383 (England and Wales)

AUDITORS:

Xeinadin Audit Ltd

12 Conqueror Ct

Sittingbourne

Kent

ME10 5BH

FIXED ASSETS

Intangible assets

4

2,968,176

2,680,988

Tangible assets

5

93,220

11,037

3,061,396

2,692,025

CURRENT ASSETS

Stocks

20,403

67,805

Debtors

6

3,738,045

4,049,391

Cash at bank

1,942,175

1,944,291

5,700,623

6,061,487

CREDITORS

Amounts falling due within one year

7

2,663,218

2,931,712

NET CURRENT ASSETS

3,037,405

3,129,775

TOTAL ASSETS LESS CURRENT LIABILITIES

6,098,801

5,821,800

PROVISIONS FOR LIABILITIES

23,217

2,030

NET ASSETS

6,075,584

5,819,770

CAPITAL AND RESERVES

Called up share capital

3,389,761

3,389,761

Retained earnings

2,685,823

2,430,009

6,075,584

5,819,770

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 30 September 2025 and were signed by:

H K Kim - Director

1.	STATUTORY INFORMATION

RNA Analytics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of five years.

Development costs are being amortised evenly over their estimated useful life of five years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

20% on cost and 15% on cost

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 21 (2023 - 23 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

£

COST

At 1 January 2024

8,978,806

Additions

1,301,872

At 31 December 2024

10,280,678

AMORTISATION

At 1 January 2024

6,297,818

Charge for year

1,014,684

At 31 December 2024

7,312,502

NET BOOK VALUE

At 31 December 2024

2,968,176

At 31 December 2023

2,680,988

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 January 2024

115,746

Additions

102,310

Disposals

(40,193

)

At 31 December 2024

177,863

DEPRECIATION

At 1 January 2024

104,709

Charge for year

20,064

Eliminated on disposal

(40,130

)

At 31 December 2024

84,643

NET BOOK VALUE

At 31 December 2024

93,220

At 31 December 2023

11,037

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Trade debtors

2,341,946

2,357,988

Amounts owed by group undertakings

1,145,695

1,040,835

Other debtors

250,404

650,568

3,738,045

4,049,391

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Hire purchase contracts

37,487

-

Trade creditors

467,038

137,338

Taxation and social security

99,000

93,201

Other creditors

2,059,693

2,701,173

2,663,218

2,931,712

8.	DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Nicholas Hume FCA (Senior Statutory Auditor)

for and on behalf of Xeinadin Audit Ltd

9.	RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

During the year, the company made sales of £48,524 (2023; £61,201) to companies with significant influence. At the year end, £747,203 (2023; £716,751) of this was outstanding.

10.	ULTIMATE CONTROLLING PARTY

The company's immediate parent is RNA Analytics Co, Ltd, incorporated in South Korea.